Appian Corp
Change company Symbol lookup
Select an option...
APPN Appian Corp
BANI Banneker Inc
DGAZ VelocityShares 3x Inverse Natural Gas ETN Linked to the S&P GSCI? Natural Gas Index ER
EPRSQ EPIRUS Biopharmaceuticals Inc
PLAY Dave & Buster's Entertainment Inc
BAC Bank of America Corp
CEMI Chembio Diagnostics Inc
MOJO MOJO Organics Inc
JSDA Jones Soda Co
NOBL ProShares S&P 500 Dividend Aristocrats ETF
Go

Information Technology : Software | Small Cap Growth
Company profile

Appian Corporation provides a low-code software development platform as a service that enables organizations to develop applications. Through Company’s platform, organizations can design, build and implement, enterprise-grade custom applications. Decision makers can reimagine their products, services, processes and customer interactions. The Company’s platform automates the creation of forms, data flows, records, reports and other software elements. The Company’s SAIL technology allows developers to create an application once and deploy it everywhere. The Company’s products include business process management (BPM) software, case management, mobile application development and platform as a service. The Company provides its services to a range of industries including energy, insurance, health payers and providers, manufacturing, public sector, retail and transportation.

Premarket

Last Trade
Delayed
$36.02
0.30 (0.84%)
Bid
--
Ask
--
B/A Size
--

Market Hours

Closing Price
$35.72
Day's Change
0.00 (0.00%)
Bid close
--
Ask close
--
B/A Size
--
Day's High
--
Day's Low
--
Volume
(Light)
Volume:
206

10-day average volume:
1,028,373
206

Ekso Bionics(R) to Report Fourth Quarter and Full Year 2019 Financial Results on February 27, 2020

8:00 am ET February 20, 2020 (Globe Newswire) Print

Ekso Bionics Holdings, Inc. (Nasdaq: EKSO), an industry leader in exoskeleton technology for medical and industrial use, today announced that it will release financial and business results for the fourth quarter and full year 2019 after the close of trading on Thursday, February 27, 2020. Management will host a conference call beginning at 1:30 p.m. PT / 4:30 p.m. ET to discuss the financial results and recent business developments.

Investors interested in listening to the conference call may do so by dialing (877) 407-3036 for domestic callers or (201) 378-4919 for international callers. A live webcast of the event will be available in the "Investors" section of the company's website at www.eksobionics.com, or by clicking here.

A replay of the call will be available for two weeks by dialing (877) 660-6853 for domestic callers or (201) 612-7415 for international callers and using Conference ID: 13698960. The webcast will also be available on the company's website for one month following the completion of the call.

About Ekso Bionics

Ekso Bionics(R) is a leading developer of exoskeleton solutions that amplify human potential by supporting or enhancing strength, endurance and mobility across medical and industrial applications. Founded in 2005, the Company continues to build upon its industry-leading expertise to design some of the most cutting-edge, innovative wearable robots available on the market. Ekso Bionics is the only exoskeleton company to offer technologies that range from helping those with paralysis to stand up and walk, to enhancing human capabilities on job sites across the globe. The Company is headquartered in the San Francisco Bay Area and is listed on the Nasdaq Capital Market under the symbol "EKSO." For more information, visit: www.eksobionics.com or follow @EksoBionics on Twitter.

Investor Contact:

David Carey

212-867-1768

investors@eksobionics.com

Media Contact:

Carrie Yamond Mas

917-371-2320

cmas@eksobionics.com

https://ml.globenewswire.com/media/b8eb3344-76d5-498f-a377-85b7a2d47c60/small/ekso-jpg.jpg

Earnings Calendar and Events Data provided by |Terms of Use| © 2020 Wall Street Horizon, Inc.

Market data accompanied by is delayed by at least 15 minutes for NASDAQ, NYSE MKT, NYSE, and options. Duration of the delay for other exchanges varies.
Market data and information provided by Morningstar.

Options are not suitable for all investors as the special risks inherent to options trading may expose investors to potentially rapid and substantial losses.
Please read Characteristics and Risks of Standard Options before investing in options.

Information and news provided by ,, , Computrade Systems, Inc., , and

Copyright © 2020. All rights reserved.